748 related articles for article (PubMed ID: 32746922)
1. A consideration of publication-derived immune-related associations in Coronavirus and related lung damaging diseases.
Geifman N; Whetton AD
J Transl Med; 2020 Aug; 18(1):297. PubMed ID: 32746922
[TBL] [Abstract][Full Text] [Related]
2. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158
[TBL] [Abstract][Full Text] [Related]
3. Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures.
Hui KPY; Cheung MC; Perera RAPM; Ng KC; Bui CHT; Ho JCW; Ng MMT; Kuok DIT; Shih KC; Tsao SW; Poon LLM; Peiris M; Nicholls JM; Chan MCW
Lancet Respir Med; 2020 Jul; 8(7):687-695. PubMed ID: 32386571
[TBL] [Abstract][Full Text] [Related]
4. From Influenza Virus to Novel Corona Virus (SARS-CoV-2)-The Contribution of Obesity.
Bhattacharya I; Ghayor C; Pérez Dominguez A; Weber FE
Front Endocrinol (Lausanne); 2020; 11():556962. PubMed ID: 33123087
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 Causes a Different Cytokine Response Compared to Other Cytokine Storm-Causing Respiratory Viruses in Severely Ill Patients.
Olbei M; Hautefort I; Modos D; Treveil A; Poletti M; Gul L; Shannon-Lowe CD; Korcsmaros T
Front Immunol; 2021; 12():629193. PubMed ID: 33732251
[TBL] [Abstract][Full Text] [Related]
6. Hypothesis for potential pathogenesis of SARS-CoV-2 infection-a review of immune changes in patients with viral pneumonia.
Lin L; Lu L; Cao W; Li T
Emerg Microbes Infect; 2020 Dec; 9(1):727-732. PubMed ID: 32196410
[TBL] [Abstract][Full Text] [Related]
7. Pro- and Anti-Inflammatory Responses in Severe COVID-19-Induced Acute Respiratory Distress Syndrome-An Observational Pilot Study.
Notz Q; Schmalzing M; Wedekink F; Schlesinger T; Gernert M; Herrmann J; Sorger L; Weismann D; Schmid B; Sitter M; Schlegel N; Kranke P; Wischhusen J; Meybohm P; Lotz C
Front Immunol; 2020; 11():581338. PubMed ID: 33123167
[TBL] [Abstract][Full Text] [Related]
8. Altered cytokine levels and immune responses in patients with SARS-CoV-2 infection and related conditions.
Noroozi R; Branicki W; Pyrc K; Łabaj PP; Pospiech E; Taheri M; Ghafouri-Fard S
Cytokine; 2020 Sep; 133():155143. PubMed ID: 32460144
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 triggers inflammatory responses and cell death through caspase-8 activation.
Li S; Zhang Y; Guan Z; Li H; Ye M; Chen X; Shen J; Zhou Y; Shi ZL; Zhou P; Peng K
Signal Transduct Target Ther; 2020 Oct; 5(1):235. PubMed ID: 33037188
[TBL] [Abstract][Full Text] [Related]
10. The possible pathophysiology mechanism of cytokine storm in elderly adults with COVID-19 infection: the contribution of "inflame-aging".
Meftahi GH; Jangravi Z; Sahraei H; Bahari Z
Inflamm Res; 2020 Sep; 69(9):825-839. PubMed ID: 32529477
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2-A Tough Opponent for the Immune System.
Nasab MG; Saghazadeh A; Rezaei N
Arch Med Res; 2020 Aug; 51(6):589-592. PubMed ID: 32532524
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 infection: the perspectives on immune responses.
Shi Y; Wang Y; Shao C; Huang J; Gan J; Huang X; Bucci E; Piacentini M; Ippolito G; Melino G
Cell Death Differ; 2020 May; 27(5):1451-1454. PubMed ID: 32205856
[No Abstract] [Full Text] [Related]
13. COVID-19, Mast Cells, Cytokine Storm, Psychological Stress, and Neuroinflammation.
Kempuraj D; Selvakumar GP; Ahmed ME; Raikwar SP; Thangavel R; Khan A; Zaheer SA; Iyer SS; Burton C; James D; Zaheer A
Neuroscientist; 2020; 26(5-6):402-414. PubMed ID: 32684080
[TBL] [Abstract][Full Text] [Related]
14. Tuberculosis and COVID-19: Lessons from the Past Viral Outbreaks and Possible Future Outcomes.
Crisan-Dabija R; Grigorescu C; Pavel CA; Artene B; Popa IV; Cernomaz A; Burlacu A
Can Respir J; 2020; 2020():1401053. PubMed ID: 32934758
[TBL] [Abstract][Full Text] [Related]
15. [Comparison of pathological changes and pathogenic mechanisms caused by H1N1 influenza virus, highly pathogenic H5N1 avian influenza virus, SARS-CoV, MERS-CoV and 2019-nCoV].
Liu M; Feng RE; Li Q; Zhang HK; Wang YG
Zhonghua Bing Li Xue Za Zhi; 2020 May; 49(5):511-516. PubMed ID: 32392945
[TBL] [Abstract][Full Text] [Related]
16. COVID-19: a conundrum to decipher.
Deshmukh V; Tripathi SC; Pandey A; Deshmukh V; Vykoukal J; Patil A; Sontakke B
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5830-5841. PubMed ID: 32495923
[TBL] [Abstract][Full Text] [Related]
17. SARS - CoV-2: Reasons of epidemiology of severe ill disease cases and therapeutic approach using trivalent vaccine (tetanus, diphtheria and Bordetella pertussis).
Ietto G
Med Hypotheses; 2020 Aug; 141():109779. PubMed ID: 32387756
[TBL] [Abstract][Full Text] [Related]
18. How to reduce the likelihood of coronavirus-19 (CoV-19 or SARS-CoV-2) infection and lung inflammation mediated by IL-1.
Conti P; Gallenga CE; Tetè G; Caraffa A; Ronconi G; Younes A; Toniato E; Ross R; Kritas SK
J Biol Regul Homeost Agents; 2020 March-April,; 34(2):333-338. PubMed ID: 32228825
[TBL] [Abstract][Full Text] [Related]
19. Long-term infection of SARS-CoV-2 changed the body's immune status.
Lin L; Luo S; Qin R; Yang M; Wang X; Yang Q; Zhang Y; Wang Q; Zhu R; Fan H; Wang H; Hu Y; Wang L; Hu D
Clin Immunol; 2020 Sep; 218():108524. PubMed ID: 32659373
[TBL] [Abstract][Full Text] [Related]
20. The Management of Cytokine Storm in COVID-19.
Rumende CM; Susanto EC; Sitorus TP
Acta Med Indones; 2020 Jul; 52(3):306-313. PubMed ID: 33020343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
